Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Aug;54(8):2181-2191.
doi: 10.1161/STROKEAHA.123.040499. Epub 2023 Jun 5.

Cognitive Impairment in Patients With Cardiac Disease: Implications for Clinical Practice

Affiliations
Review

Cognitive Impairment in Patients With Cardiac Disease: Implications for Clinical Practice

Astrid C van Nieuwkerk et al. Stroke. 2023 Aug.

Abstract

Cognitive impairment is common in patients with cardiovascular disease. One in 3 patients presenting at cardiology clinics have some degree of cognitive impairment, depending on the cardiac condition, comorbidities, and age. In up to half of these cases cognitive impairment may go unrecognized; however, it may affect self-management and treatment adherence. The high prevalence of cognitive impairment in patients with cardiac disease is likely due to shared risk factors, as well as direct consequences of cardiac dysfunction on the brain. Moreover, cardiac interventions may have beneficial as well as adverse effects on cognitive functioning. In this review, we describe prevalence and risk factors for cognitive impairment in patients with several common cardiac conditions: heart failure, coronary artery disease, and aortic valve stenosis. We discuss the potential effects of guideline-based treatments on cognition and identify open questions and unmet needs. Given the high prevalence of unrecognized cognitive impairment in cardiac patients, we recommend a stepwise approach to improve detection and management of cognitive impairment.

Keywords: aortic valve stenosis; cardiovascular disease; cognition; cognitive dysfunction; coronary artery disease; heart failure; prevalence.

PubMed Disclaimer

Conflict of interest statement

Disclosures Dr Wolters was consultant for the PGGM pension fund (fees paid to institution) and received research grants from the Brain & Behavior Research Foundation, The Netherlands Organisation for Health Research and Development (ZonMw) and The Alzheimer’s Association, outside of the submitted work. Dr Biessels also receives research funding from The Netherlands Organisation for Health Research and Development (ZonMw), Vici grant 918.16.616. Dr Delewi received educational fees from Boston Scientific and Edwards Lifesciences. The other authors report no conflicts.

Publication types

MeSH terms